KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer
Approximately 50-75% of patients with serous ovarian carcinoma (SOC) experience recurrence within 18 months after first-line treatment. Current clinical indicators are inadequate for predicting the risk of recurrence. In this study, we used 7 publicly available microarray datasets to identify gene s...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190068/ |